glyxambi
Generic: empagliflozin and linagliptin
Labeler: boehringer ingelheim pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
glyxambi
Generic Name
empagliflozin and linagliptin
Labeler
boehringer ingelheim pharmaceuticals, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
empagliflozin 10 mg/1, linagliptin 5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0597-0182
Product ID
0597-0182_16f275d5-7526-4e7a-8776-665a9a6ae37a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA206073
Listing Expiration
2027-12-31
Marketing Start
2015-01-30
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
05970182
Hyphenated Format
0597-0182
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
glyxambi (source: ndc)
Generic Name
empagliflozin and linagliptin (source: ndc)
Application Number
NDA206073 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/1
- 5 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (0597-0182-30)
- 30 BLISTER PACK in 1 CARTON (0597-0182-39) / 1 TABLET, FILM COATED in 1 BLISTER PACK
- 90 TABLET, FILM COATED in 1 BOTTLE (0597-0182-90)
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "16f275d5-7526-4e7a-8776-665a9a6ae37a", "openfda": {"nui": ["N0000187059", "N0000187058", "N0000175912", "N0000175913"], "unii": ["HDC1R2M35U", "3X29ZEJ4R2"], "rxcui": ["1602109", "1602115", "1602118", "1602120"], "spl_set_id": ["ddbab689-f76c-488c-9613-4168d41dd730"], "pharm_class_epc": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Sodium-Glucose Transporter 2 Inhibitors [MoA]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0597-0182-30)", "package_ndc": "0597-0182-30", "marketing_start_date": "20150130"}, {"sample": false, "description": "30 BLISTER PACK in 1 CARTON (0597-0182-39) / 1 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "0597-0182-39", "marketing_start_date": "20150130"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (0597-0182-90)", "package_ndc": "0597-0182-90", "marketing_start_date": "20150130"}], "brand_name": "Glyxambi", "product_id": "0597-0182_16f275d5-7526-4e7a-8776-665a9a6ae37a", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "0597-0182", "generic_name": "empagliflozin and linagliptin", "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Glyxambi", "active_ingredients": [{"name": "EMPAGLIFLOZIN", "strength": "10 mg/1"}, {"name": "LINAGLIPTIN", "strength": "5 mg/1"}], "application_number": "NDA206073", "marketing_category": "NDA", "marketing_start_date": "20150130", "listing_expiration_date": "20271231"}